Free Trial

Clever Leaves Q4 2022 Earnings Report

Clever Leaves logo
$0.0001 0.00 (-50.00%)
(As of 12/24/2024 02:37 PM ET)

Clever Leaves Earnings Headlines

First JFK… next Elon?
Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.
See More Clever Leaves Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Clever Leaves? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clever Leaves and other key companies, straight to your email.

About Clever Leaves

Clever Leaves (NASDAQ:CLVR) operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

View Clever Leaves Profile

More Earnings Resources from MarketBeat